Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin Gel vs Hydroquinone in Hyperpigmentation
NCT05511948Phase 2Completed
- Sponsor
- DermBiont, Inc.
- Start
- Aug 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruboxistaurin in Hyperpigmentation, sponsored by DermBiont, Inc.. Started Aug 2022; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on NCT05511948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05511948.